Viral infections in the neonate

Newborn and Infant Nursing Reviews

Volumn 10, Issue 4, 2010, Pages 195-202

  O'Keefe, Catherine ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Congenital infection; Cytomegalovirus; Herpes simplex virus; HIV; Neonatal infection

Indexed keywords

EID: 78649463159     PISSN: 15273369     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.nainr.2010.09.008     Document Type: Article

References (49)

1. Pass R. Viral infections in the fetus and neonate. Principles and practice of pediatric infectious diseases 2008, 539-554. Elsevier, Philadelphia (PA). 3rd ed. S. Long, L. Pickering, C. Prober (Eds.).
2. Smith P.B., Benjamin D.K. Clinical approach to the infected neonate. Principles and practice of pediatric infectious diseases 2008, 530-531. Elsevier, Philadelphia (PA). 3rd ed. S. Long, L. Pickering, C. Prober (Eds.).
3. de la Morena M. Immunologic development and susceptibility to infection. Principles and practice of pediatric infectious diseases 2008, 86-93. Elsevier, Philadelphia (PA). 3rd ed. S. Long, L. Pickering, C. Prober (Eds.).
4. American Academy of Pediatrics Transmission of infectious agents via human milk. Red Book: 2009 report of the committee on infectious diseases 2009, 120-128. American Academy of Pediatrics, Elk Grove Village (IL). 28th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
5. Bate S.L., Dollar S.C., Cannon M.J. Cytomegalovirus seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988-2004. CID 2010, 50:1439-1447.
6. Ghandi R.S., Fernandez-Alvarez J.R., Rabe H. Management of congenital cytomegalovirus infection. Acta Paediatrica. 2010, 99:509-515.
7. Nassetta L., Kimberlin D.K., Whitley R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemo. 2009, 63:862-867.
8. Cannon M.J. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Viro. 2009, 46S:S6-S10.
9. Yamamoto A.Y., Mussi-Pinhata M.M., Boppana S.B., et al. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol. 2010, 202:e1-e8.
10. Ross S.A., Arora N., Novak Z., et al. Cytomegalovirus reinfections in healthy seroimmune women. JID 2010, 201:386-389.
11. Marshall B.C., Koch W.C. Antivirals for cytomegalovirus infection in neonates and infants. Pediatr Drugs 2009, 11:309-321.
12. Read J.S., Cannon M.J., Stanberry L.R., Schuval S. Prevention of mother-to-child transmission of viral infections. Curr Probl Pediatr Adolesc Health Care 2008, 38:274-297.
13. Demler-Harrison G.J. Congenital cytomegalovirus: public health action towards awareness, prevention, and treatment. J Clin Virol. 2009, 46S:S1-S5.
14. Benoist G., Salomon L.J., Mohlo M., et al. Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet Gynecol. 2008, 32:900-905.
15. Kenneson A., Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007, 17:253-276.
16. Ross S.A., Novak Z., Fowler K.B., et al. Cytomegalovirus blood viral load and hearing loss in young children with congenital infection. Pediatr Infect Dis J. 2009, 28:588-592.
17. Foulon I., Naessens A., Foulon W., Casteels A., Gordts F. A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr. 2008, 153:84-88.
18. Boppanna SB, Ross SA, Novak Z, et al.. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 303(14): 1375-1382.
19. Kimberlin D.W., Lin C.Y., Sanchez P.J., et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003, 143:16-25.
20. Oliver S.E., Cloud G.A., Sanchez P.J., et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009, 46S:S22-S26.
21. Rosenthal L.S., Fowler K.B., Boppanna S.B., et al. Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J. 2009, 28:515-520.
22. Dollard S.C., Grosse S.D., Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007, 17:315-329.
23. Ross D.S., Victor M., Sumartojo E., Cannon M.J. Women's knowledge of congenital cytomegalovirus: results from the 2005 HealthStyles survey. J Womens Health 2008, 17:849-858.
24. Centers for Disease Control and Prevention Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008, 57:65-68.
25. Pass R.F., Zhang C., Evans A., et al. Vaccine prevention of maternal cytomegalovirus infection. New Engl J Med. 2009, 360:1191-1199.
26. Adler S.P., Nigro G. Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol. 2009, 46D:S54-S57.
27. Nigro G., Adler S.P., La Torre R., Best A.M. Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. New Engl J Med. 2005, 353:1350-1362.
28. Cahill A.G., Odibo A.O., Stamilo D.M., Macones G.A. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol. 2009, 201:e1-e7.
29. American Academy of Pediatrics Cytomegalovirus: control measures. Red book: 2009 report of the committee on infectious diseases 2009, 279. American Academy of Pediatrics, Elk Grove Village (IL). 28th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
30. Stowell J.D., Forlin-Passoni D., Cannon M.J. Congenital cytomegalovirus: an update. Contemp Pediatr 2010, 38-51.
31. Kimberlin D.W. Herpes simplex virus infections of the newborn. Semin Perinatol 2007, 31:19-25.
32. Corey L., Wald A. Maternal and neonatal herpes simplex virus infections. New Engl J Med. 2009, 361:1376-1385.
33. American Academy of Pediatrics Herpes Simplex. Red book: 2009 report of the committee on infectious diseases 2009, 363-373. American Academy of Pediatrics, Elk Grove Village (IL). 28th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
34. Roberts S. Herpes simplex virus: incidence of neonatal herpes simplex virus, maternal screening, management during pregnancy, and HIV. Curr Opin Obste Gynecol. 2009, 21:124-130.
35. Shah S.S., Volk J., Mohamad Z., Hodinka R.L., Zorc J.J. Herpes simplex virus testing and hospital length of stay in neonates and young infants. J Pediatr. 2010, 156:738-743.
36. Cohen D.M., Lorch S.A., King R.L., et al. Factors influencing the decision to test young infants for herpes simplex virus infection. Pediatr Infect Dis J. 2007, 26:1156-1158.
37. Caviness A.C., Demmler G.J., Swint M., Cantor S.B. Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates. Arch Pediatr Adolesc Med. 2008, 162:665-674.
38. American Academy of Pediatrics Antiviral drugs. Red book: 2009 report of the committee on infectious diseases 2009, 777. American Academy of Pediatrics, Elk Grove Village (IL). 28th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
39. Jones C.A. Vertical transmission of genital herpes: prevention and treatment options. Drugs. 2009 2009, 69:421-434.
40. Kimberlin D., Powell D., Gruber W., et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dise J. 1996, 15:247-254.
41. ACOG Management of Herpes in Pregnancy. Obstet. & Gynecol. 2007, 109:1489-1498.
42. Jones C.A., Walker K.S., Badawi N. Antiviral agents for treatment of herpes simplex virus infection in neonates (Review). Cochrane Database of Systematic Reviews 2009, 3:CD004206.
43. Centers for Disease Control and Prevention Racial/ethnic disparities among children with diagnoses of perinatal HIV infection-34 states, 2004-2007. MMWR Morb Mortal Wkly Rep. 2010, 59:97-101.
44. Centers for Disease Control and Prevention Revised recommendations for IV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Morb Mortal Wkly Rep. 2006, 55:1-17.
45. Buchanan A.M., Cunningham C.K. Advances and failures in preventing perinatal human immunodeficiency virus infection. Clin Micro Rev. 2009, 22:493-507.
46. Health and Human Services Recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV transmission Available at:. http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf.
47. Committee on Pediatric AIDS HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics 2008, 122:1127-1134.
48. American Academy of Pediatrics Human immunodeficiency virus infection. Red book: 2009 report of the committee on infectious diseases 2009, 380-400. American Academy of Pediatrics, Elk Grove Village (IL). 28th ed. L.K. Pickering, C.J. Baker, D.W. Kimberlin, S.S. Long (Eds.).
49. Bradley J.S., Nelson J.D. Nelson's pocket book of antimicrobial therapy 2010, 29. American Academy of Pediatrics. 18th ed.